BackgroundCheck.run
Search For

Samuel L Page, 40Hagerstown, MD

Known as:
Samuel C Page
Related to:
Calvin M Harvey 76 Yolonda R Watkins 60 Katrina D Poge 46 Speller Jaia 39 Speller Jaia 48 Jennifer Brunson 50

Samuel Page Phones & Addresses

Hagerstown, MD   

Oxon Hill, MD   

3130 Bohannon Ave, Louisville, KY 40215    502-3642558    502-3644252   

Leonardtown, MD   

Temple Hills, MD   

Work

Company: Aoac international, inc. Address: 481 N Frederick Ave # 500, Gaithersburg, MD 20877 Phones: 301-9247077 Position: President elect/president Industries: Professional Membership Organizations
Get Report
Control this profile

Mentions for Samuel L Page

Career records & work history

Lawyers & Attorneys

Samuel Page Photo 1

Samuel Page - Lawyer

Office:
Davis Polk & Wardwell LLP
Specialties:
Mergers and Acquisitions
ISLN:
1000255420
Admitted:
2017
University:
Princeton University, A.B., 2010; Yale School of Management, M.B.A., 2016
Law School:
Yale Law School, J.D., 2016

Samuel Page resumes & CV records

Resumes

Samuel Page Photo 42

Associate At Paine & Partners

Position:
Associate at Paine & Partners, LLC
Location:
Chicago, Illinois
Industry:
Venture Capital & Private Equity
Work:
Paine & Partners, LLC since Apr 2012
Associate Goldman Sachs Jul 2010 - Feb 2012
Analyst Goldman Sachs Jun 2009 - Aug 2009
Summer Analyst Aviva Investors Jan 2008 - Jun 2008
Intern
Education:
University of Iowa - Henry B. Tippie College of Business 2005 - 2010
BBA, Finance, Economics
Samuel Page Photo 43

Samuel Page

Samuel Page Photo 44

Samuel Page

Publications & IP owners

Us Patents

Evaluative Means For Detecting Inflammatory Reactivity

US Patent:
5348729, Sep 20, 1994
Filed:
May 5, 1992
Appl. No.:
7/878608
Inventors:
Esther M. Sternberg - Chevy Chase MD
Philip W. Gold - Washington DC
Samuel W. Page - Silver Spring MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:
G01N 100
G01N 3348
A61K 3760
A61K 4505
US Classification:
424 9
Abstract:
The present invention is directed to a method for testing the susceptibility of a mammal to inflammatory diseases which comprises the steps of: administering to a mammal a compound selected from the group consisting of Type 1 mineralocorticoid receptor antagonists, opiate antagonists, estrogen antagonists or mixed estrogen agonists/antagonists, progesterone agonists; or a combination of an estrogen antagonist with one or a combination of a Type I glucocorticoid receptor antagonist, a Type II glucocorticoid agonist or a progesterone agonist which is effective in stimulating the hypothalamic-pituitary-adrenal (HPA) axis; and measuring the level of at least one hormone secreted by the hypothalamus, pituitary or adrenal glands of said mammal. The present invention is also directed to methods of treating inflammatory diseases.

Possible Relatives

Cynthia A Page  David K Page  Dawn G Page  Dean A Page  Deana L Page  Deane J Page  Deanna Page  Samuel C Johnson  Samuel J Stanage  Samuel Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.